Le, NJ
Anh Le, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20110015227 | WARMING SENSATE COMPOSITION - The invention relates to a warming sensate composition of (i) a hot component, (ii) a cooling component, and (iii) optionally a bitter component. The weight ratio of (i):(ii) is from 1:3 to 1:100. If a solvent is provided in the composition, the solvent is present in an amount of less than 10 wt % ethanol, based on the total weight of the composition. Also, the bitter component, when used, is present in an amount of less than 0.15% by weight based on the total weight of the composition. | 01-20-2011 |
20120129953 | TINGLING AND SALIVATING COMPOSITIONS - A sensate composition comprises a salivating component, a tingling component and a flavor, the salivating component being formed of at least a mixture of citric, malic and succinic acid, or of their salts, and the tingling component being formed of an ingredient selected from the group consisting of Jambu oleoresin, spilanthol, any extract containing either or both, and their mixtures. The sensate composition allows the preparation of consumer products having improved salivating properties. | 05-24-2012 |
Dung T. Le, Mullical Hill, NJ US
Patent application number | Description | Published |
---|---|---|
20140213548 | SYSTEM AND METHOD FOR HEMOSTATIC WOUND DRESSING - The present invention relates a novel hemostatic wound dressing, preferably comprising chitosan and an oxygen carrier such as a perfluorocarbon, and methods to treat hemorrhaging wounds and MRSA infections. The present invention helps with coagulation/clot formation as well as providing oxygen to the wound, all while being cost effective and competitive with current hemostatic dressings. | 07-31-2014 |
Henry Trong Le, Englewood Cliffs, NJ US
Patent application number | Description | Published |
---|---|---|
20120115945 | FERRIC CITRATE DOSAGE FORMS - The disclosure relates to ferric citrate tablets and dosage forms. | 05-10-2012 |
20130274328 | FERRIC CITRATE DOSAGE FORMS - Disclosed herein are ferric citrate-containing tablets. In various embodiments, the tablets include ferric citrate formulations that meet certain dissolution, tableting and disintegration standards. In various aspects, the tablet formulations can include ferric citrate as the active ingredient and a binder. The formulations also can include a lubricant and/or a disintegrant (which, in some embodiments, can be the same as the binder). | 10-17-2013 |
Hung Le, Rockaway, NJ US
Patent application number | Description | Published |
---|---|---|
20090209483 | TREATMENTS FOR FLAVIVIRIDAE VIRUS INFECTION - The present invention provides methods for treating infections, in a host, by viruses belonging to the Flaviviridae family, such as HCV, comprising administering an Ara-C homologue to the host. | 08-20-2009 |
20110033422 | TREATMENTS FOR FLAVIVIRIDAE VIRUS INFECTION - The present invention provides methods for treating infections, in a host, by viruses belonging to the Flaviviridae family, such as HCV, comprising administering an Ara-C homologue to the host. | 02-10-2011 |
Hung V. Le, Rockaway, NJ US
Patent application number | Description | Published |
---|---|---|
20080199447 | CATALYTIC DOMAIN OF ADAM33 AND METHODS OF USE THEREOF - The present invention discloses purified polypeptides that comprise an active ADAM33 catalytic domain. In addition, the present invention discloses nucleic acids that encode the polypeptides of the present invention. The present invention also discloses methods of growing X-ray diffractable crystals of polypeptides comprising the active ADAM33 catalytic domain. In addition, the present invention discloses methods of using the X-ray diffractable crystals of ADAM33 in structure-based drug design to identify compounds that can modulate the enzymatic activity of ADAM33. The present invention also discloses methods of treating respiratory disorders by administering therapeutic amounts of the ADAM33 catalytic domain. | 08-21-2008 |
20100267150 | HDM2 POLYPEPTIDES - The present invention relates to HDM2 polypeptides and mutants thereof which are complexed with various compounds, e.g., HDM2 inhibitors. | 10-21-2010 |
20120214181 | ASSAY FOR PCSK9 INHIBITORS - The present invention provides methods for identifying modulators of PCSK9, for example, using a variety of assay formats. Inhibitors of PCSK9 can be used for example, to treat diseases such as hyperlipidemia and related disorders. | 08-23-2012 |
Kang Le, Green Brook, NJ US
Patent application number | Description | Published |
---|---|---|
20100160308 | Thiazolyl-Benzimidazoles - The invention is directed to compounds of formula (1) | 06-24-2010 |
20150210739 | AZAHETEROCYCLES AS BIR2 AND/OR BIR3 INHIBITORS - Disclosed are compounds of Formula (I) or pharmaceutically acceptable salts thereof, wherein R | 07-30-2015 |
Kim-Phuong Nguyen Le, Dunellen, NJ US
Patent application number | Description | Published |
---|---|---|
20150266210 | ANNEALING METHOD FOR CROSS-LINKED POLYETHYLENE - A method for making an ultra-high weight polyethylene (UHMWPE) medical implant starts with obtaining a preform consolidated from UHMWPE resin. Thereafter the preform is hot isostaticly pressed at a temperature between 150° C. and 190° C. at a pressure up to 30,000 psi. After the hot isostatic pressing the preform is sequentially irradiated in a solid state at a total radiation dose of 2 to 10 MRad. The irradiated UHMWPE preform is then heated to a temperature of about 110° C. to about 190° C. for between 2 to 10 hours. The irradiated and heated preform is then cooled after each irradiation and heating to at or below 50° C., and thereafter a medical implant is formed from the preform. Alternately, the process can be performed on the medical implant itself. | 09-24-2015 |
Minh Le, Edison, NJ US
Patent application number | Description | Published |
---|---|---|
20120287585 | MODULAR CORE ENGINE (CE) RADIO ARCHITECTURE - A compact communications radio core engine (CE) module includes a modem circuit board having a first connector, and a radio frequency (RF) circuit board having a second connector configured to mate with the first connector of the modem circuit card. A module shell is constructed and arranged to contain the modem and the RF circuit boards in such an orientation so that the second connector of the RF circuit board can operatively engage the first connector of the modem circuit card. | 11-15-2012 |
Nam T. Le, Verona, NJ US
Patent application number | Description | Published |
---|---|---|
20130178460 | THIENOPYRIMIDINE COMPOUNDS - The present invention relates to the use of novel compounds of Formula I: | 07-11-2013 |
Thu Anh Le, Bridgewater, NJ US
Patent application number | Description | Published |
---|---|---|
20130037596 | DEVICE FOR APPLYING ADJUNCT IN ENDOSCOPIC PROCEDURE - A modular end effector delivers a therapeutic agent onto tissue that has been severed and/or stapled. The end effector is removably attached to a device. The device applies force to a piston of the end effector. The force causes a distal movement of a piston along a wall disposed within the end effector. The piston engages with agents stored on opposite sides of the wall, moving the agents distally to a mixture space. The agents are mixed in the mixture space and expelled through a tip. Staples may be embedded in or disposed below a foam block, which is disposed within a staple cartridge. Via an endoscopic stapling device, coated staples are driven through tissue while interacting with another agent on the device or the cartridge. The interaction forms a tissue restoring material that is applied onto the tissue. | 02-14-2013 |
20130041406 | SURGICAL STAPLE WITH LOCALIZED ADJUNCT COATING - A medical fastener has a first, pre-deployment shape for loading into a surgical instrument, and a second, post-deployment shape for connecting tissue together, and includes a crown and a pair of legs, each leg substantially transversely extending from a respective end of the crown in the first, pre-deployment shape. A coating, such as a hemostatic agent, is applied to a fastener interior surface defined by interior surfaces of the crown and the pair of legs. | 02-14-2013 |
20130075447 | ADJUNCT THERAPY DEVICE FOR APPLYING HEMOSTATIC AGENT - A surgical instrument includes a handle portion, a shaft housing a firing bar, an end effector comprising an anvil, a lower jaw, and a stapling and severing assembly responsive to a longitudinal closing motion produced by the handle portion and the shaft. The lower jaw is configured to receive a removable cartridge. The cartridge includes a housing, a plurality of staples disposed in the housing, and a deck disposed over the plurality of staples. The deck defines apertures, with each aperture being substantially disposed over each staple. The cartridge further receives a buttress material stored in one or both of the anvil or cartridge. The material is releasable onto severed tissue via a firing bar severing the buttress material in response to the longitudinal closing motion. | 03-28-2013 |
Thuy X. E. Le, Monmouth Junction, NJ US
Patent application number | Description | Published |
---|---|---|
20080200445 | Heterocyclic aspartyl protease inhibitors - Disclosed are compounds of the formula I | 08-21-2008 |
20120231017 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 09-13-2012 |
20120231018 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 09-13-2012 |
Thuy X.e. Le, Monmouth Junction, NJ US
Patent application number | Description | Published |
---|---|---|
20120276118 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 11-01-2012 |
20140206715 | PREPARATION AND USE OF COMPOUNDS AS PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 07-24-2014 |
Thuy X.h. Le, Monmouth Junction, NJ US
Patent application number | Description | Published |
---|---|---|
20090258868 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 10-15-2009 |
20090306047 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 12-10-2009 |
20100152138 | CYCLIC AMINE BACE-1 INHIBITORS HAVING A BENZAMIDE SUBSTITUENT - Disclosed are compounds of the formula | 06-17-2010 |
20130018066 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 01-17-2013 |
20130102609 | BIARYL OXYACETIC ACID COMPOUNDS - The present invention provides biaryl oxyacetic acid compounds which may be useful for treating inflammatory disorders, including disorders affecting the respiratory system and skin. The compounds provided include those of the general formula I: | 04-25-2013 |
20140057910 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 02-27-2014 |
20140128361 | CYCLIC AMIDE BACE-1 INHIBITORS HAVING A BENZAMIDE SUBSTITUENT - Disclosed are compounds of the formula | 05-08-2014 |
20150105354 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 04-16-2015 |
Thuy X.h. Le, Monmouth Junciton, NJ US
Patent application number | Description | Published |
---|---|---|
20130004518 | CYCLIC AMINE BACE-1 INHIBITORS HAVING A BENZAMIDE SUBSTITUENT - Disclosed are compounds of the formula | 01-03-2013 |
Thuy X. H. Le, Monmouth Junction, NJ US
Patent application number | Description | Published |
---|---|---|
20090312341 | CYCLIC AMINE BACE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT - Disclosed are novel compounds of the formula | 12-17-2009 |
20110136877 | 2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS - The present invention provides novel phenoxyacetic acids useful for the prevention and treatment of inflammatory disorders, including those affecting the respiratory system and skin. The compounds are of the general formula (I): | 06-09-2011 |
20110218194 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 09-08-2011 |
Tieu-Binh Le, Bridgewater, NJ US
Patent application number | Description | Published |
---|---|---|
20100113462 | SUBSTITUTED BENZOYLAMINO-INDAN-2-CARBOXYLIC ACIDS AND RELATED COMPOUNDS - The present invention relates to novel compounds of the formula I: | 05-06-2010 |
Viet Le, Marlton, NJ US
Patent application number | Description | Published |
---|---|---|
20140032748 | CONFIGURABLE NETWORK MONITORING METHODS, SYSTEMS, AND APPARATUS - Configurable network monitoring systems, apparatus, and methods are described. The configurable system includes storage devices, processing modules, and a system chassis housing the processing modules. Each processing module includes a processing unit, a network interface card coupled to the processing unit and configured for receiving data from a communication network, a storage controller coupled to the processing unit and configured to access a corresponding one of the storage devices, and a module chassis housing the processing unit, the network interface card, and the storage controller. The system can be reconfigured by adding/removing processing modules from the system chassis. | 01-30-2014 |